Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles.

Lymphatic metastasis is an important prognostic factor regarding long-term survival rate of gastric cancer (GC) patients. Pretreatment knowledge of lymph node status is extremely helpful for planning treatment and prognosis. However, to date, no imaging method has been demonstrated to be effective for detecting lymphatic metastasis in GC. Molecular imaging probes based on upconversion nanoparticles with unique optical and magnetic properties have provided great hope for early tumor detection. Herein we report highly sensitive detection of lymphatic spread using core@shell structured NaGdF4:Yb,Er@NaGdF4 upconversion nanoparticles coated with polyethylene glycol (PEG). A GC-specific probe was constructed through "click" reaction between the maleimide moiety of PEG ligand and the thiol group from partly reduced antigastric cancer antibody MGb2. The primary tumor and adjacent lymphatic metastasis site were clearly differentiated by upconversion luminescence imaging after the GC-specific probe was delivered through tail vein injection into tumor-bearing mice. Moreover, lymphatic metastases smaller than 1 mm were successfully detected, owing to the ultralow background under 980 nm excitation. It has been demonstrated that both primary and lymphatic metastatic sites in an orthotopic mouse model of human gastric cancer can be optically detected by using GC-specific upconversion luminescence nanoprobes. The current studies may therefore provide a highly effective approach for GC diagnosis.

[1]  Xiaogang Liu,et al.  Recent Advances in the Chemistry of Lanthanide‐Doped Upconversion Nanocrystals , 2009 .

[2]  Greg J. Stanisz,et al.  Size-Tunable, Ultrasmall NaGdF4 Nanoparticles: Insights into Their T1 MRI Contrast Enhancement , 2011 .

[3]  刘春艳,et al.  Are Rare-Earth Nanoparticles Suitable for In Vivo Applications? , 2014 .

[4]  Ralph Weissleder,et al.  Upconverting luminescent nanomaterials: application to in vivo bioimaging. , 2009, Chemical communications.

[5]  F. Fang,et al.  NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo. , 2013, ACS Nano.

[6]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[7]  D. Fan,et al.  Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker. , 2009, Cancer letters.

[8]  Y. Nie,et al.  In vivo molecular imaging of gastric cancer in human-murine xenograft models with confocal laser endomicroscopy using a tumor vascular homing peptide. , 2015, Cancer letters.

[9]  Mingyuan Gao,et al.  Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo. , 2013, ACS nano.

[10]  C. González,et al.  Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go , 2012, International journal of cancer.

[11]  R. Weissleder Molecular Imaging in Cancer , 2006, Science.

[12]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[13]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[14]  D. Fan,et al.  Mouse and human monoclonal antibodies against gastric cancer. Preparation and clinical application. , 1988, Chinese medical journal.

[15]  Jimin Liang,et al.  Real-time bioluminescence and tomographic imaging of gastric cancer in a novel orthotopic mouse model. , 2012, Oncology reports.

[16]  Christopher G. Morgan,et al.  The Active‐Core/Active‐Shell Approach: A Strategy to Enhance the Upconversion Luminescence in Lanthanide‐Doped Nanoparticles , 2009 .

[17]  Yong Zhang,et al.  Synthesis of hexagonal-phase core-shell NaYF4 nanocrystals with tunable upconversion fluorescence. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[18]  Yang Yang,et al.  Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. , 2010, Biomaterials.

[19]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[20]  Taeghwan Hyeon,et al.  Theranostic Probe Based on Lanthanide‐Doped Nanoparticles for Simultaneous In Vivo Dual‐Modal Imaging and Photodynamic Therapy , 2012, Advanced materials.

[21]  Fuyou Li,et al.  High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. , 2009, Analytical chemistry.

[22]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[23]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[24]  Ya-Wen Zhang,et al.  Highly Efficient Multicolor Up-Conversion Emissions and Their Mechanisms of Monodisperse NaYF4:Yb,Er Core and Core/Shell-Structured Nanocrystals , 2007 .

[25]  P. Choyke,et al.  In vivo multiple color lymphatic imaging using upconverting nanocrystals , 2009 .

[26]  A. Hölscher,et al.  Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. , 1999, AJR. American journal of roentgenology.

[27]  Shan Jiang,et al.  Multicolor Core/Shell‐Structured Upconversion Fluorescent Nanoparticles , 2008 .

[28]  Shiwei Wu,et al.  Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals , 2009, Proceedings of the National Academy of Sciences.

[29]  Junichi Hasegawa,et al.  New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice , 2013, Gastric Cancer.

[30]  Hu Jl,et al.  Mouse and human monoclonal antibodies against gastric cancer. Preparation and clinical application. , 1988 .

[31]  Frank C J M van Veggel,et al.  Surface modification of upconverting NaYF4 nanoparticles with PEG-phosphate ligands for NIR (800 nm) biolabeling within the biological window. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[32]  Zhuang Liu,et al.  Upconversion nanophosphors for small-animal imaging. , 2012, Chemical Society reviews.

[33]  T. Kwee,et al.  Imaging in assessing lymph node status in gastric cancer , 2009, Gastric Cancer.

[34]  Mizuo Maeda,et al.  Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. , 2009, Biochemical and biophysical research communications.

[35]  Zhi-Gang Chen,et al.  Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. , 2009, Biomaterials.

[36]  F. V. Veggel,et al.  Hard Proof of the NaYF4/NaGdF4 Nanocrystal Core/ Shell Structure [J. Am. Chem. Soc. 2009, 131, 14644―14645] , 2010 .

[37]  D. Ribatti,et al.  The use of the orthotopic model to validate antivascular therapies for cancer. , 2011, The International journal of developmental biology.

[38]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.

[39]  P. Lu,et al.  Predictive factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on the surgical strategy. , 2008, World journal of gastroenterology.

[40]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[41]  R. Hoffman Orthotopic is orthodox: Why are orthotopic‐transplant metastatic models different from all other models? , 1994, Journal of cellular biochemistry.

[42]  Taeghwan Hyeon,et al.  Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent , 2009 .

[43]  Wing-Cheung Law,et al.  Core/shell NaGdF4:Nd(3+)/NaGdF4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications. , 2012, ACS nano.